1 Study Coverage
1.1 Dihydrocodeine Product Introduction
1.2 Market by Type
1.2.1 Global Dihydrocodeine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Dihydrocodeine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cough Suppressant
1.3.3 Analgesic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dihydrocodeine Sales Estimates and Forecasts 2017-2028
2.2 Global Dihydrocodeine Revenue Estimates and Forecasts 2017-2028
2.3 Global Dihydrocodeine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dihydrocodeine Sales by Region
2.4.1 Global Dihydrocodeine Sales by Region (2017-2022)
2.4.2 Global Sales Dihydrocodeine by Region (2023-2028)
2.5 Global Dihydrocodeine Revenue by Region
2.5.1 Global Dihydrocodeine Revenue by Region (2017-2022)
2.5.2 Global Dihydrocodeine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dihydrocodeine Sales by Manufacturers
3.1.1 Global Top Dihydrocodeine Manufacturers by Sales (2017-2022)
3.1.2 Global Dihydrocodeine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dihydrocodeine in 2021
3.2 Global Dihydrocodeine Revenue by Manufacturers
3.2.1 Global Dihydrocodeine Revenue by Manufacturers (2017-2022)
3.2.2 Global Dihydrocodeine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dihydrocodeine Revenue in 2021
3.3 Global Dihydrocodeine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dihydrocodeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dihydrocodeine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dihydrocodeine Sales by Type
4.1.1 Global Dihydrocodeine Historical Sales by Type (2017-2022)
4.1.2 Global Dihydrocodeine Forecasted Sales by Type (2023-2028)
4.1.3 Global Dihydrocodeine Sales Market Share by Type (2017-2028)
4.2 Global Dihydrocodeine Revenue by Type
4.2.1 Global Dihydrocodeine Historical Revenue by Type (2017-2022)
4.2.2 Global Dihydrocodeine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Dihydrocodeine Revenue Market Share by Type (2017-2028)
4.3 Global Dihydrocodeine Price by Type
4.3.1 Global Dihydrocodeine Price by Type (2017-2022)
4.3.2 Global Dihydrocodeine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Dihydrocodeine Sales by Application
5.1.1 Global Dihydrocodeine Historical Sales by Application (2017-2022)
5.1.2 Global Dihydrocodeine Forecasted Sales by Application (2023-2028)
5.1.3 Global Dihydrocodeine Sales Market Share by Application (2017-2028)
5.2 Global Dihydrocodeine Revenue by Application
5.2.1 Global Dihydrocodeine Historical Revenue by Application (2017-2022)
5.2.2 Global Dihydrocodeine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dihydrocodeine Revenue Market Share by Application (2017-2028)
5.3 Global Dihydrocodeine Price by Application
5.3.1 Global Dihydrocodeine Price by Application (2017-2022)
5.3.2 Global Dihydrocodeine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dihydrocodeine Market Size by Type
6.1.1 North America Dihydrocodeine Sales by Type (2017-2028)
6.1.2 North America Dihydrocodeine Revenue by Type (2017-2028)
6.2 North America Dihydrocodeine Market Size by Application
6.2.1 North America Dihydrocodeine Sales by Application (2017-2028)
6.2.2 North America Dihydrocodeine Revenue by Application (2017-2028)
6.3 North America Dihydrocodeine Market Size by Country
6.3.1 North America Dihydrocodeine Sales by Country (2017-2028)
6.3.2 North America Dihydrocodeine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Dihydrocodeine Market Size by Type
7.1.1 Europe Dihydrocodeine Sales by Type (2017-2028)
7.1.2 Europe Dihydrocodeine Revenue by Type (2017-2028)
7.2 Europe Dihydrocodeine Market Size by Application
7.2.1 Europe Dihydrocodeine Sales by Application (2017-2028)
7.2.2 Europe Dihydrocodeine Revenue by Application (2017-2028)
7.3 Europe Dihydrocodeine Market Size by Country
7.3.1 Europe Dihydrocodeine Sales by Country (2017-2028)
7.3.2 Europe Dihydrocodeine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dihydrocodeine Market Size by Type
8.1.1 Asia Pacific Dihydrocodeine Sales by Type (2017-2028)
8.1.2 Asia Pacific Dihydrocodeine Revenue by Type (2017-2028)
8.2 Asia Pacific Dihydrocodeine Market Size by Application
8.2.1 Asia Pacific Dihydrocodeine Sales by Application (2017-2028)
8.2.2 Asia Pacific Dihydrocodeine Revenue by Application (2017-2028)
8.3 Asia Pacific Dihydrocodeine Market Size by Region
8.3.1 Asia Pacific Dihydrocodeine Sales by Region (2017-2028)
8.3.2 Asia Pacific Dihydrocodeine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Dihydrocodeine Market Size by Type
9.1.1 Latin America Dihydrocodeine Sales by Type (2017-2028)
9.1.2 Latin America Dihydrocodeine Revenue by Type (2017-2028)
9.2 Latin America Dihydrocodeine Market Size by Application
9.2.1 Latin America Dihydrocodeine Sales by Application (2017-2028)
9.2.2 Latin America Dihydrocodeine Revenue by Application (2017-2028)
9.3 Latin America Dihydrocodeine Market Size by Country
9.3.1 Latin America Dihydrocodeine Sales by Country (2017-2028)
9.3.2 Latin America Dihydrocodeine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Dihydrocodeine Market Size by Type
10.1.1 Middle East and Africa Dihydrocodeine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Dihydrocodeine Revenue by Type (2017-2028)
10.2 Middle East and Africa Dihydrocodeine Market Size by Application
10.2.1 Middle East and Africa Dihydrocodeine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dihydrocodeine Revenue by Application (2017-2028)
10.3 Middle East and Africa Dihydrocodeine Market Size by Country
10.3.1 Middle East and Africa Dihydrocodeine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dihydrocodeine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AHPL
11.1.1 AHPL Corporation Information
11.1.2 AHPL Overview
11.1.3 AHPL Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AHPL Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AHPL Recent Developments
11.2 Teofarma
11.2.1 Teofarma Corporation Information
11.2.2 Teofarma Overview
11.2.3 Teofarma Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teofarma Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teofarma Recent Developments
11.3 Mundipharma
11.3.1 Mundipharma Corporation Information
11.3.2 Mundipharma Overview
11.3.3 Mundipharma Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mundipharma Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mundipharma Recent Developments
11.4 Napp Pharmaceuticals
11.4.1 Napp Pharmaceuticals Corporation Information
11.4.2 Napp Pharmaceuticals Overview
11.4.3 Napp Pharmaceuticals Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Napp Pharmaceuticals Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Napp Pharmaceuticals Recent Developments
11.5 Aspen Pharmacare
11.5.1 Aspen Pharmacare Corporation Information
11.5.2 Aspen Pharmacare Overview
11.5.3 Aspen Pharmacare Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Aspen Pharmacare Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aspen Pharmacare Recent Developments
11.6 Martindale-Hubbell
11.6.1 Martindale-Hubbell Corporation Information
11.6.2 Martindale-Hubbell Overview
11.6.3 Martindale-Hubbell Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Martindale-Hubbell Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Martindale-Hubbell Recent Developments
11.7 Duopharma Biotech Berhad
11.7.1 Duopharma Biotech Berhad Corporation Information
11.7.2 Duopharma Biotech Berhad Overview
11.7.3 Duopharma Biotech Berhad Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Duopharma Biotech Berhad Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Duopharma Biotech Berhad Recent Developments
11.8 Wockhardt
11.8.1 Wockhardt Corporation Information
11.8.2 Wockhardt Overview
11.8.3 Wockhardt Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Wockhardt Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wockhardt Recent Developments
11.9 Auden Mckenzie Pharma
11.9.1 Auden Mckenzie Pharma Corporation Information
11.9.2 Auden Mckenzie Pharma Overview
11.9.3 Auden Mckenzie Pharma Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Auden Mckenzie Pharma Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Auden Mckenzie Pharma Recent Developments
11.10 WraSer
11.10.1 WraSer Corporation Information
11.10.2 WraSer Overview
11.10.3 WraSer Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 WraSer Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 WraSer Recent Developments
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Corporation Information
11.11.2 GlaxoSmithKline Overview
11.11.3 GlaxoSmithKline Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 GlaxoSmithKline Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 GlaxoSmithKline Recent Developments
11.12 G.L. Pharma
11.12.1 G.L. Pharma Corporation Information
11.12.2 G.L. Pharma Overview
11.12.3 G.L. Pharma Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 G.L. Pharma Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 G.L. Pharma Recent Developments
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Corporation Information
11.13.2 Daiichi Sankyo Overview
11.13.3 Daiichi Sankyo Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Daiichi Sankyo Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Daiichi Sankyo Recent Developments
11.14 Fuso Pharmaceutical
11.14.1 Fuso Pharmaceutical Corporation Information
11.14.2 Fuso Pharmaceutical Overview
11.14.3 Fuso Pharmaceutical Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Fuso Pharmaceutical Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Fuso Pharmaceutical Recent Developments
11.15 Nichi-Iko Pharmaceutical
11.15.1 Nichi-Iko Pharmaceutical Corporation Information
11.15.2 Nichi-Iko Pharmaceutical Overview
11.15.3 Nichi-Iko Pharmaceutical Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Nichi-Iko Pharmaceutical Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Nichi-Iko Pharmaceutical Recent Developments
11.16 Takata Pharmaceutical
11.16.1 Takata Pharmaceutical Corporation Information
11.16.2 Takata Pharmaceutical Overview
11.16.3 Takata Pharmaceutical Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Takata Pharmaceutical Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Takata Pharmaceutical Recent Developments
11.17 Toyo Seikan Group
11.17.1 Toyo Seikan Group Corporation Information
11.17.2 Toyo Seikan Group Overview
11.17.3 Toyo Seikan Group Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Toyo Seikan Group Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Toyo Seikan Group Recent Developments
11.18 Teva
11.18.1 Teva Corporation Information
11.18.2 Teva Overview
11.18.3 Teva Dihydrocodeine Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Teva Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Teva Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dihydrocodeine Industry Chain Analysis
12.2 Dihydrocodeine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dihydrocodeine Production Mode & Process
12.4 Dihydrocodeine Sales and Marketing
12.4.1 Dihydrocodeine Sales Channels
12.4.2 Dihydrocodeine Distributors
12.5 Dihydrocodeine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dihydrocodeine Industry Trends
13.2 Dihydrocodeine Market Drivers
13.3 Dihydrocodeine Market Challenges
13.4 Dihydrocodeine Market Restraints
14 Key Findings in The Global Dihydrocodeine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Dihydrocodeine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Injection
Table 4. Global Dihydrocodeine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Dihydrocodeine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Dihydrocodeine Sales by Region (2017-2022) & (K Units)
Table 7. Global Dihydrocodeine Sales Market Share by Region (2017-2022)
Table 8. Global Dihydrocodeine Sales by Region (2023-2028) & (K Units)
Table 9. Global Dihydrocodeine Sales Market Share by Region (2023-2028)
Table 10. Global Dihydrocodeine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Dihydrocodeine Revenue Market Share by Region (2017-2022)
Table 12. Global Dihydrocodeine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Dihydrocodeine Revenue Market Share by Region (2023-2028)
Table 14. Global Dihydrocodeine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Dihydrocodeine Sales Share by Manufacturers (2017-2022)
Table 16. Global Dihydrocodeine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Dihydrocodeine Revenue Share by Manufacturers (2017-2022)
Table 18. Dihydrocodeine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Dihydrocodeine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Dihydrocodeine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dihydrocodeine as of 2021)
Table 21. Dihydrocodeine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Dihydrocodeine Product Offered
Table 23. Date of Manufacturers Enter into Dihydrocodeine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Dihydrocodeine Sales by Type (2017-2022) & (K Units)
Table 26. Global Dihydrocodeine Sales by Type (2023-2028) & (K Units)
Table 27. Global Dihydrocodeine Sales Share by Type (2017-2022)
Table 28. Global Dihydrocodeine Sales Share by Type (2023-2028)
Table 29. Global Dihydrocodeine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Dihydrocodeine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Dihydrocodeine Revenue Share by Type (2017-2022)
Table 32. Global Dihydrocodeine Revenue Share by Type (2023-2028)
Table 33. Dihydrocodeine Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Dihydrocodeine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Dihydrocodeine Sales by Application (2017-2022) & (K Units)
Table 36. Global Dihydrocodeine Sales by Application (2023-2028) & (K Units)
Table 37. Global Dihydrocodeine Sales Share by Application (2017-2022)
Table 38. Global Dihydrocodeine Sales Share by Application (2023-2028)
Table 39. Global Dihydrocodeine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Dihydrocodeine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Dihydrocodeine Revenue Share by Application (2017-2022)
Table 42. Global Dihydrocodeine Revenue Share by Application (2023-2028)
Table 43. Dihydrocodeine Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Dihydrocodeine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Dihydrocodeine Sales by Type (2017-2022) & (K Units)
Table 46. North America Dihydrocodeine Sales by Type (2023-2028) & (K Units)
Table 47. North America Dihydrocodeine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Dihydrocodeine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Dihydrocodeine Sales by Application (2017-2022) & (K Units)
Table 50. North America Dihydrocodeine Sales by Application (2023-2028) & (K Units)
Table 51. North America Dihydrocodeine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Dihydrocodeine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Dihydrocodeine Sales by Country (2017-2022) & (K Units)
Table 54. North America Dihydrocodeine Sales by Country (2023-2028) & (K Units)
Table 55. North America Dihydrocodeine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Dihydrocodeine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Dihydrocodeine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Dihydrocodeine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Dihydrocodeine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Dihydrocodeine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Dihydrocodeine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Dihydrocodeine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Dihydrocodeine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Dihydrocodeine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Dihydrocodeine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Dihydrocodeine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Dihydrocodeine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Dihydrocodeine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Dihydrocodeine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Dihydrocodeine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Dihydrocodeine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Dihydrocodeine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Dihydrocodeine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Dihydrocodeine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Dihydrocodeine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Dihydrocodeine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Dihydrocodeine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Dihydrocodeine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Dihydrocodeine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Dihydrocodeine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Dihydrocodeine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Dihydrocodeine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Dihydrocodeine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Dihydrocodeine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Dihydrocodeine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Dihydrocodeine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Dihydrocodeine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Dihydrocodeine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Dihydrocodeine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Dihydrocodeine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Dihydrocodeine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Dihydrocodeine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Dihydrocodeine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Dihydrocodeine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Dihydrocodeine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Dihydrocodeine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Dihydrocodeine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Dihydrocodeine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Dihydrocodeine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Dihydrocodeine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Dihydrocodeine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Dihydrocodeine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Dihydrocodeine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Dihydrocodeine Revenue by Country (2023-2028) & (US$ Million)
Table 105. AHPL Corporation Information
Table 106. AHPL Description and Major Businesses
Table 107. AHPL Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. AHPL Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. AHPL Recent Developments
Table 110. Teofarma Corporation Information
Table 111. Teofarma Description and Major Businesses
Table 112. Teofarma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Teofarma Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Teofarma Recent Developments
Table 115. Mundipharma Corporation Information
Table 116. Mundipharma Description and Major Businesses
Table 117. Mundipharma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Mundipharma Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Mundipharma Recent Developments
Table 120. Napp Pharmaceuticals Corporation Information
Table 121. Napp Pharmaceuticals Description and Major Businesses
Table 122. Napp Pharmaceuticals Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Napp Pharmaceuticals Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Napp Pharmaceuticals Recent Developments
Table 125. Aspen Pharmacare Corporation Information
Table 126. Aspen Pharmacare Description and Major Businesses
Table 127. Aspen Pharmacare Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Aspen Pharmacare Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Aspen Pharmacare Recent Developments
Table 130. Martindale-Hubbell Corporation Information
Table 131. Martindale-Hubbell Description and Major Businesses
Table 132. Martindale-Hubbell Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Martindale-Hubbell Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Martindale-Hubbell Recent Developments
Table 135. Duopharma Biotech Berhad Corporation Information
Table 136. Duopharma Biotech Berhad Description and Major Businesses
Table 137. Duopharma Biotech Berhad Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Duopharma Biotech Berhad Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Duopharma Biotech Berhad Recent Developments
Table 140. Wockhardt Corporation Information
Table 141. Wockhardt Description and Major Businesses
Table 142. Wockhardt Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Wockhardt Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Wockhardt Recent Developments
Table 145. Auden Mckenzie Pharma Corporation Information
Table 146. Auden Mckenzie Pharma Description and Major Businesses
Table 147. Auden Mckenzie Pharma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Auden Mckenzie Pharma Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Auden Mckenzie Pharma Recent Developments
Table 150. WraSer Corporation Information
Table 151. WraSer Description and Major Businesses
Table 152. WraSer Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. WraSer Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. WraSer Recent Developments
Table 155. GlaxoSmithKline Corporation Information
Table 156. GlaxoSmithKline Description and Major Businesses
Table 157. GlaxoSmithKline Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. GlaxoSmithKline Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. GlaxoSmithKline Recent Developments
Table 160. G.L. Pharma Corporation Information
Table 161. G.L. Pharma Description and Major Businesses
Table 162. G.L. Pharma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. G.L. Pharma Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. G.L. Pharma Recent Developments
Table 165. Daiichi Sankyo Corporation Information
Table 166. Daiichi Sankyo Description and Major Businesses
Table 167. Daiichi Sankyo Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. Daiichi Sankyo Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Daiichi Sankyo Recent Developments
Table 170. Fuso Pharmaceutical Corporation Information
Table 171. Fuso Pharmaceutical Description and Major Businesses
Table 172. Fuso Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 173. Fuso Pharmaceutical Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Fuso Pharmaceutical Recent Developments
Table 175. Nichi-Iko Pharmaceutical Corporation Information
Table 176. Nichi-Iko Pharmaceutical Description and Major Businesses
Table 177. Nichi-Iko Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 178. Nichi-Iko Pharmaceutical Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Nichi-Iko Pharmaceutical Recent Developments
Table 180. Takata Pharmaceutical Corporation Information
Table 181. Takata Pharmaceutical Description and Major Businesses
Table 182. Takata Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 183. Takata Pharmaceutical Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Takata Pharmaceutical Recent Developments
Table 185. Toyo Seikan Group Corporation Information
Table 186. Toyo Seikan Group Description and Major Businesses
Table 187. Toyo Seikan Group Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 188. Toyo Seikan Group Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Toyo Seikan Group Recent Developments
Table 190. Teva Corporation Information
Table 191. Teva Description and Major Businesses
Table 192. Teva Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 193. Teva Dihydrocodeine Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Teva Recent Developments
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Dihydrocodeine Distributors List
Table 198. Dihydrocodeine Customers List
Table 199. Dihydrocodeine Market Trends
Table 200. Dihydrocodeine Market Drivers
Table 201. Dihydrocodeine Market Challenges
Table 202. Dihydrocodeine Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Dihydrocodeine Product Picture
Figure 3. Global Dihydrocodeine Market Share by Type in 2021 & 2028
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Dihydrocodeine Market Share by Application in 2021 & 2028
Figure 6. Cough Suppressant
Figure 7. Analgesic
Figure 8. Dihydrocodeine Report Years Considered
Figure 9. Global Dihydrocodeine Sales 2017-2028 (K Units)
Figure 10. Global Dihydrocodeine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Dihydrocodeine Revenue 2017-2028 (US$ Million)
Figure 12. Global Dihydrocodeine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Dihydrocodeine Sales Market Share by Region (2017-2022)
Figure 14. Global Dihydrocodeine Sales Market Share by Region (2023-2028)
Figure 15. North America Dihydrocodeine Sales YoY (2017-2028) & (K Units)
Figure 16. North America Dihydrocodeine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Dihydrocodeine Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Dihydrocodeine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Dihydrocodeine Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Dihydrocodeine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Dihydrocodeine Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Dihydrocodeine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Dihydrocodeine Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Dihydrocodeine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Dihydrocodeine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Dihydrocodeine in the World: Market Share by Dihydrocodeine Revenue in 2021
Figure 27. Global Dihydrocodeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Dihydrocodeine Sales Market Share by Type (2017-2028)
Figure 29. Global Dihydrocodeine Revenue Market Share by Type (2017-2028)
Figure 30. Global Dihydrocodeine Sales Market Share by Application (2017-2028)
Figure 31. Global Dihydrocodeine Revenue Market Share by Application (2017-2028)
Figure 32. North America Dihydrocodeine Sales Market Share by Type (2017-2028)
Figure 33. North America Dihydrocodeine Revenue Market Share by Type (2017-2028)
Figure 34. North America Dihydrocodeine Sales Market Share by Application (2017-2028)
Figure 35. North America Dihydrocodeine Revenue Market Share by Application (2017-2028)
Figure 36. North America Dihydrocodeine Sales Share by Country (2017-2028)
Figure 37. North America Dihydrocodeine Revenue Share by Country (2017-2028)
Figure 38. United States Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Dihydrocodeine Sales Market Share by Type (2017-2028)
Figure 41. Europe Dihydrocodeine Revenue Market Share by Type (2017-2028)
Figure 42. Europe Dihydrocodeine Sales Market Share by Application (2017-2028)
Figure 43. Europe Dihydrocodeine Revenue Market Share by Application (2017-2028)
Figure 44. Europe Dihydrocodeine Sales Share by Country (2017-2028)
Figure 45. Europe Dihydrocodeine Revenue Share by Country (2017-2028)
Figure 46. Germany Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 47. France Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Dihydrocodeine Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Dihydrocodeine Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Dihydrocodeine Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Dihydrocodeine Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Dihydrocodeine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Dihydrocodeine Revenue Share by Region (2017-2028)
Figure 57. China Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 60. India Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Dihydrocodeine Sales Market Share by Type (2017-2028)
Figure 67. Latin America Dihydrocodeine Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Dihydrocodeine Sales Market Share by Application (2017-2028)
Figure 69. Latin America Dihydrocodeine Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Dihydrocodeine Sales Share by Country (2017-2028)
Figure 71. Latin America Dihydrocodeine Revenue Share by Country (2017-2028)
Figure 72. Mexico Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Dihydrocodeine Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Dihydrocodeine Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Dihydrocodeine Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Dihydrocodeine Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Dihydrocodeine Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Dihydrocodeine Revenue Share by Country (2017-2028)
Figure 81. Turkey Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Dihydrocodeine Revenue (2017-2028) & (US$ Million)
Figure 84. Dihydrocodeine Value Chain
Figure 85. Dihydrocodeine Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
